Evidence map›Paper›PMID 38466480›Full record

ArticleJournal of cancer survivorship : research and practice2025

Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study.

Ismay A E de Beijer, Emma C Hardijzer, Riccardo Haupt, Desiree Grabow, Julia Balaguer, Edit Bardi, Adela Cañete Nieto, Audronė Ciesiūniene, Vanessa Düster, Anna-Liesa Filbert and 15 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Ismay A E de BeijerPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. i.a.e.debeijer-3@prinsesmaximacentrum.nl.
Emma C HardijzerPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Riccardo HauptIRCCS Istituto Giannina Gaslini, Genoa, Italy.
Desiree GrabowDivision of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, of the Johannes Gutenberg University Mainz, Mainz, Germany.
Julia BalaguerHospital Universitario y Politécnico La Fe, Valencia, Spain.
Edit BardiSt. Anna Children's Hospital, Vienna, Austria.
Adela Cañete NietoHospital Universitario y Politécnico La Fe, Valencia, Spain.
Audronė CiesiūnieneVilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Vanessa DüsterSt. Anna Children's Hospital and Children's Cancer Research Institute, Department of Studies and Statistics for Integrated Research and Projects, Department of Paediatrics, Medical University of Vienna, Vienna, Austria.
Anna-Liesa FilbertDivision of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, of the Johannes Gutenberg University Mainz, Mainz, Germany.
Hannah GsellCCI Europe, Vienna, Austria.
Monika KapitančukėVilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Ruth LadensteinSt. Anna Children's Hospital and Children's Cancer Research Institute, Department of Studies and Statistics for Integrated Research and Projects, Department of Paediatrics, Medical University of Vienna, Vienna, Austria.
Thorsten LangerUniversitatsklinikum Schleswig-Holstein, Campus Lubeck, Lübeck, Germany.
Monica MuracaIRCCS Istituto Giannina Gaslini, Genoa, Italy.
Selina R van den OeverPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Sofie PrikkenUniversity Hospitals Leuven, KU Leuven, Louvain, Belgium.
Jelena RasconVilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Maria Teresa TormoInstituto de Investigación Sanitaria La Fe, Valencia, Spain.
Anne UyttebroeckUniversity Hospitals Leuven, KU Leuven, Louvain, Belgium.
Gertrui VercruysseUniversity Hospitals Leuven, KU Leuven, Louvain, Belgium.
Helena J H van der PalPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Leontien C M KremerPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
Saskia M F PluijmPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
PanCareSurPass consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38466480
PMCPMC12081557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.